Daniel Richardson
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Research Interests
Daniel Richardson has a total of 14 co-authors. Here are the top co-authors by number of shared publications:
David Goldmeier
Jane Wadsworth Clinic, Jefferiss Wing, St Mary's Hospital, London W2 1NY, UK
6 shared publicationsBASHH Special Interest Group for Sexual Dysfunction
2 shared publications- John Green
Central and North West London NHS Foundation Trust, London, UK
2 shared publications A R Wright
Department of Clinical Radiology St Mary’s Hospital, London, UK
1 shared publicationA Rice
Department of Histopathology, St Mary’s Hospital, London, UK
1 shared publicationAgnes Kocsis
1 shared publication
Latest Publications
- 1 January 2006
- Published by SAGE Publications in International Journal of STD & AIDS
- Vol. 17 (1) , 1-6
Recommendations for the management of premature ejaculation: BASHH Special Interest Group for Sexual Dysfunction
We present the British Association for Sexual Health and HIV (BASHH), Special Interest Group for Sexual Dysfunction updated recommendations for the management of premature ejaculation. The recommendations outline the physiology, prevalence, definitions, aetiological factors and patient assessment for this common sexual problem. Behavioural, local and systemic pharmacological treatments are discussed along with general recommendations and auditable outcomes.
- 1 January 2006
- Published by SAGE Publications in International Journal of STD & AIDS
- Vol. 17 (1) , 1-6
Recommendations for the management of premature ejaculation: BASHH Special Interest Group for Sexual Dysfunction
We present the British Association for Sexual Health and HIV (BASHH), Special Interest Group for Sexual Dysfunction updated recommendations for the management of premature ejaculation. The recommendations outline the physiology, prevalence, definitions, aetiological factors and patient assessment for this common sexual problem. Behavioural, local and systemic pharmacological treatments are discussed along with general recommendations and auditable outcomes.
- 1 January 2006
- Published by SAGE Publications in International Journal of STD & AIDS
- Vol. 17 (1) , 7-13
Recommendations for the management of retarded ejaculation: BASHH Special Interest Group for Sexual Dysfunction
We present the British Association of Sexual Health and HIV (BASHH) special interest group in sexual dysfunction recommendations for the management of retarded ejaculation. The recommendations outline the physiology, prevalence, definitions, aetiological factors and patient assessment for this sexual problem. We suggest treatment strategies, recommendations for management and an auditable outcome.
- 1 January 2006
- Published by SAGE Publications in International Journal of STD & AIDS
- Vol. 17 (1) , 7-13
Recommendations for the management of retarded ejaculation: BASHH Special Interest Group for Sexual Dysfunction
We present the British Association of Sexual Health and HIV (BASHH) special interest group in sexual dysfunction recommendations for the management of retarded ejaculation. The recommendations outline the physiology, prevalence, definitions, aetiological factors and patient assessment for this sexual problem. We suggest treatment strategies, recommendations for management and an auditable outcome.
- 1 October 2005
- Published by SAGE Publications in International Journal of STD & AIDS
- Vol. 16 (10) , 651-658
A review of controlled trials in the pharmacological treatment of premature ejaculation
Search and browse 5 million articles across 13,000 publications from over 250 publishers by publication, subject, publisher, author or keyword.
- 1 October 2005
- Published by SAGE Publications in International Journal of STD & AIDS
- Vol. 16 (10) , 651-658
A review of controlled trials in the pharmacological treatment of premature ejaculation
Search and browse 5 million articles across 13,000 publications from over 250 publishers by publication, subject, publisher, author or keyword.
- 1 October 2005
- Published by SAGE Publications in International Journal of STD & AIDS
- Vol. 16 (10) , 709-711
Pharmacological treatment for premature ejaculation
Search and browse 5 million articles across 13,000 publications from over 250 publishers by publication, subject, publisher, author or keyword.
- 1 October 2005
- Published by SAGE Publications in International Journal of STD & AIDS
- Vol. 16 (10) , 709-711
Pharmacological treatment for premature ejaculation
Search and browse 5 million articles across 13,000 publications from over 250 publishers by publication, subject, publisher, author or keyword.
- Open Access
Cystic lung lesions as an immune reconstitution inflammatory syndrome (IRIS) in HIV-TB co-infection?
Standard antituberculous treatment was commenced and he improved clinically. Four weeks later anti-HIV treatment was introduced. He became febrile again and his clinical status deteriorated with fevers up to 40°C, weight loss, and increased acute phase responses.
Open AccessCystic lung lesions as an immune reconstitution inflammatory syndrome (IRIS) in HIV-TB co-infection?
Standard antituberculous treatment was commenced and he improved clinically. Four weeks later anti-HIV treatment was introduced. He became febrile again and his clinical status deteriorated with fevers up to 40°C, weight loss, and increased acute phase responses.
- 1 July 2005
- Published by Oxford University Press (OUP) in The Journal of Sexual Medicine
- Vol. 2 (4) , 508-512
Premature Ejaculation—Does Country of Origin Tell Us Anything About Etiology?
Introduction: Premature ejaculation is a common sexual problem. The etiology of this condition is unclear. It has been suggested that some racial groups may be more at risk than others. We had a clinical impression that in our unit in London, UK, there was a preponderance of men from Islamic and Asian backgrounds. Aim: We therefore undertook a retrospective analysis of our clinic population over an eighteen-month period. Methods: A total of 123 patients were identified with a clinical diagnosis of PE based on the DSM-IV and UK national guidelines. Main Outcome Measure: Demographic and clinical data were collected retrospectively: parameters of patients seen in the previous 18 months were identified, including self-identified ethnicity and age. Patient-defined ethnicity was compared with the ethnicity of self-referring patients attending our general sexual health services (outpatients), and also with local population census data. Results: A total of 60% of patients were from Islamic or Asian backgrounds but 12% and 11% came from those racial groups in local population census data and our general clinic population respectively (P < 0.001). Conclusions: It thus appears that there is a preponderance of men from Islamic and Asian backgrounds presenting to our unit with premature ejaculation. The reasons for this are unclear. Possible mechanisms include psychosocial, familial, or genetic influences.
- 1 July 2005
- Published by Oxford University Press (OUP) in The Journal of Sexual Medicine
- Vol. 2 (4) , 508-512
Premature Ejaculation—Does Country of Origin Tell Us Anything About Etiology?
Introduction: Premature ejaculation is a common sexual problem. The etiology of this condition is unclear. It has been suggested that some racial groups may be more at risk than others. We had a clinical impression that in our unit in London, UK, there was a preponderance of men from Islamic and Asian backgrounds. Aim: We therefore undertook a retrospective analysis of our clinic population over an eighteen-month period. Methods: A total of 123 patients were identified with a clinical diagnosis of PE based on the DSM-IV and UK national guidelines. Main Outcome Measure: Demographic and clinical data were collected retrospectively: parameters of patients seen in the previous 18 months were identified, including self-identified ethnicity and age. Patient-defined ethnicity was compared with the ethnicity of self-referring patients attending our general sexual health services (outpatients), and also with local population census data. Results: A total of 60% of patients were from Islamic or Asian backgrounds but 12% and 11% came from those racial groups in local population census data and our general clinic population respectively (P < 0.001). Conclusions: It thus appears that there is a preponderance of men from Islamic and Asian backgrounds presenting to our unit with premature ejaculation. The reasons for this are unclear. Possible mechanisms include psychosocial, familial, or genetic influences.
- 1 February 2005
- Published by Taylor & Francis in Sexual and Relationship Therapy
- Vol. 20 (1) , 65-69
PDE5 Inhibitors may help some women with sexual problems
Female sexual dysfunction affects many women some of the time. Pharmacological research and treatments for sexual dysfunctions risk oversimplifying sexual problems in both sexes but particularly women because this promotes genital function as the centrepiece of sexuality but ignores other important components of sexual functioning such as psychosocial and relationship issues. However, there is some evidence that phosphodiesterase 5 (PDE5) inhibitors may be beneficial for some women with genital arousal disorder. We report on four anecdotal cases of women with a clinical diagnosis of female sexual arousal disorder that responded to a PDE5 inhibitor. We also report results of a questionnaire of PDE5 inhibitor prescribing practices to women in the UK. We suggest that judicious use of PDE5 inhibitors in women may be useful in some patients and that other therapists have similar views.
- 1 February 2005
- Published by Taylor & Francis in Sexual and Relationship Therapy
- Vol. 20 (1) , 65-69
PDE5 Inhibitors may help some women with sexual problems
Female sexual dysfunction affects many women some of the time. Pharmacological research and treatments for sexual dysfunctions risk oversimplifying sexual problems in both sexes but particularly women because this promotes genital function as the centrepiece of sexuality but ignores other important components of sexual functioning such as psychosocial and relationship issues. However, there is some evidence that phosphodiesterase 5 (PDE5) inhibitors may be beneficial for some women with genital arousal disorder. We report on four anecdotal cases of women with a clinical diagnosis of female sexual arousal disorder that responded to a PDE5 inhibitor. We also report results of a questionnaire of PDE5 inhibitor prescribing practices to women in the UK. We suggest that judicious use of PDE5 inhibitors in women may be useful in some patients and that other therapists have similar views.